Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€143.96
16.04.24
€183.36
16.04.25
8.21%
16:17

Piper Sandler 
16.04.24 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€17.60
16.04.24
€35.70
16.04.25
19.32%
26.04.24

BTIG Research 
16.04.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€36.23
16.04.24
€46.98
16.04.25
2.40%
02.05.24

Benchmark Co. 
16.04.24 50%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
16.04.24
-
16.04.25
-
28.12.23

Oppenheimer Holdings Inc. 
16.04.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€19.90
16.04.24
€44.18
16.04.25
24.62%
02.05.24

SVB Leerink LLC 
16.04.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€162.85
16.04.24
€191.76
16.04.25
-7.28%
15:44

Stifel Nicolaus 
16.04.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€707.70
15.04.24
€766.92
15.04.25
-3.67%
16:19

Cantor Fitzgerald 
15.04.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€24.55
15.04.24
€42.30
15.04.25
4.56%
16:18

Cantor Fitzgerald 
15.04.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€139.82
15.04.24
€202.12
15.04.25
-1.26%
16:20

Cantor Fitzgerald 
15.04.24 50%
buy
Cipher Pharmaceuticals

Start price
Target price
Perf. (%)
€6.20
15.04.24
€8.00
15.04.25
-5.65%
02.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 70%
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.59
15.04.24
€2.40
28.02.26
-1.38%
16:14

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 70%
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€38.80
15.04.24
€50.00
30.06.26
-8.25%
02.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 70%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-13.86%
28.04.24

Could be worthwhile Investment >10% per year
thomasw 
14.04.24 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1.85
14.04.24
-
14.04.25
1.08%
02.05.24

StockNews.com 
14.04.24 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.35
14.04.24
-
14.04.25
6.46%
02.05.24

StockNews.com 
14.04.24 50%
buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€3.86
14.04.24
-
14.04.25
12.95%
02.05.24

StockNews.com 
14.04.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€856.40
13.04.24
-
13.04.25
2.17%
15:43

StockNews.com 
13.04.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€371.25
13.04.24
-
13.04.25
0.74%
15:53

StockNews.com 
13.04.24 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
13.04.24
-
13.04.25
-
07.01.23

StockNews.com 
13.04.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€140.85
13.04.24
-
13.04.25
1.42%
16:06

StockNews.com 
13.04.24 50%
buy
MEI Pharma Inc.

Start price
Target price
Perf. (%)
€4.38
13.04.24
-
13.04.25
-
22.07.23

StockNews.com 
13.04.24 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
13.04.24
-
13.04.25
-
21.03.24

StockNews.com 
13.04.24 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%